Bcl-2 antagonist killer 1 (BAK1) polymorphisms influence the risk of developing autoimmune rheumatic diseases in women

Objective: Bcl-2 antagonist killer 1 (BAK1) is a Bcl-2 family proapoptotic member suggested as a candidate gene for autoimmune diseases. The influence of BAK1 polymorphisms on the risk of developing autoimmune rheumatic diseases (AIRDs) in women was investigated. Methods: A total of 719 Colombian wo...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:

2010

Institución:

Universidad del Rosario

Repositorio:

Repositorio EdocUR - U. Rosario

Idioma:

eng

OAI Identifier:

oai:repository.urosario.edu.co:10336/22378

Acceso en línea:

https://doi.org/10.1136/ard.2008.100818
https://repository.urosario.edu.co/handle/10336/22378

Palabra clave:

Bcl 2 antagonist killer 1
HLA DQB1 antigen
HLA DR antigen
Protein bcl 2
Unclassified drug
Adult
Article
Autoimmune disease
BAK1 gene
Colombia
Disease predisposition
DNA polymorphism
Dot hybridization
Female
Gene
Gene linkage disequilibrium
HLA typing
Human
Major clinical study
Priority journal
Rheumatic disease
Rheumatoid arthritis
Single nucleotide polymorphism
Sjoegren syndrome
Systemic lupus erythematosus
Autoimmune Diseases
Bcl-2 Homologous Antagonist-Killer Protein
Case-Control Studies
Colombia
Female
Genetic Predisposition to Disease
Histocompatibility Testing
HLA-DQ Antigens
HLA-DR Antigens
Humans
Linkage Disequilibrium
Polymerase Chain Reaction
Rheumatic Diseases
Sjogren's Syndrome
Single-Stranded Conformational
Systemic
Rheumatoid
Single Nucleotide
Arthritis
Lupus Erythematosus
Polymorphism
Polymorphism

Rights

License

Abierto (Texto Completo)